The energy savings associated with GLP-1 agonists like Ozempic, Wegovy, and Others

Could this decade’s biggest energy breakthrough be found at the pharmacy?

Steve Balogh, PhD

Despite all the buzz surrounding the growth of renewable energy production, efficient appliances, electric vehicles, and heat pumps, new weight control medicines have the potential to unlock more energy savings and reducing GHG than many of these technologies. We are already seeing dramatic shifts in food consumption, behavior, and health and well-being from GLP-1 agonists.

This article is for paid subscribers.

If you're a paid subscriber, you can log in here.

If you're not a paid subscriber, you can register to access member's only content here.